Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 48
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

ZHEJIANG JUTAI PHARM

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 49
  • 0 comments

FDA approve AMANTADINE HYDROCHLORIDE

Comment Full text

INFORLIFE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 48
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

UNIQUE

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 52
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 43
  • 0 comments

FDA approve AMPICILLIN SODIUM; SULBACTAM SODIUM

Comment Full text

SANDOZ

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 46
  • 0 comments

FDA approve AMPICILLIN SODIUM; SULBACTAM SODIUM

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 55
  • 0 comments

FDA approve PENCICLOVIR

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 45
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 30, 2024, 08:53 UTC
  • 52
  • 0 comments

FDA approve OCTREOTIDE ACETATE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Sept. 27, 2024, 21:50 UTC
  • 56
  • 0 comments

FDA approve USTEKINUMAB-AAUZ

Comment Full text
  • Previous
  • 340
  • 341
  • 342
  • 343
  • 344
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158460)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin